Abstract
BackgroundIL-1 pathway plays a major role in the pathogenesis of Adult onset Still's disease (AOSD). IL-1 inhibitors [Anakinra (ANK) and Canakinumab (CAN)] proved their efficacy in AOSD as demonstrated in...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have